You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTNM Sale Disclosure
Lorrain Daniel S. · SEC Form 4 · Filed Jul 2, 2026
Sale
Calculated transaction value
$91.68K
Lorrain Daniel S. Chief Scientific Officer
CTNM
Transaction date
Jul 1, 2026
Public filing date
Jul 2, 2026
Filing lag
Filed 1 day later
CTNM daily price context
Close on/before transaction
$15.24
Jul 1, 2026
First close after public filing
$15.53
Jul 6, 2026
30-day return after filing
+2.58%
Through Aug 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 5,852 shares @ $15.67
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-047058
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$627.92K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Contineum Therapeutics, Inc. CTNM Current | Sale | Jul 1, 2026 | $91.68K |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jul 1, 2026 | $4.22K |
| Contineum Therapeutics, Inc. CTNM | Sale | Jul 1, 2026 | $40.61K |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jul 1, 2026 | $0 |
| Contineum Therapeutics, Inc. CTNM | Sale | Jun 30, 2026 | $462.29K |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jun 30, 2026 | $0 |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jun 30, 2026 | $29.11K |